To design and evaluate a thermostable Rabies Virus Vectored Ebola Vaccine. As Ebola exists in some of the poorest parts of the world where the climate is tropical, the development of a thermostable vaccine could be cost-effective, resulting in greater long-term vaccine stability in high ambient temperatures.
Funding Partners:
Thomas Jefferson University
Program Partners:
CDC's National Center for Emerging and Zoonotic Infectious Diseases
